These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 19180113
1. Casting doubt on the safety of "off-the-shelf" mesenchymal stem cells for cell therapy. Rameshwar P. Mol Ther; 2009 Feb; 17(2):216-8. PubMed ID: 19180113 [No Abstract] [Full Text] [Related]
2. Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients. Campeau PM, Rafei M, François M, Birman E, Forner KA, Galipeau J. Mol Ther; 2009 Feb; 17(2):369-72. PubMed ID: 19088705 [Abstract] [Full Text] [Related]
3. Safety and Efficacy of Human Adipose-Derived Stromal/Stem Cell Therapy in an Immunocompetent Murine Pressure Ulcer Model. Bukowska J, Alarcon Uquillas A, Wu X, Frazier T, Walendzik K, Vanek M, Gaupp D, Bunnell BA, Kosnik P, Mehrara B, Katz AJ, Gawronska-Kozak B, Gimble JM. Stem Cells Dev; 2020 Apr 01; 29(7):440-451. PubMed ID: 31950878 [Abstract] [Full Text] [Related]
4. Therapeutic applications of mesenchymal stromal cells. Brooke G, Cook M, Blair C, Han R, Heazlewood C, Jones B, Kambouris M, Kollar K, McTaggart S, Pelekanos R, Rice A, Rossetti T, Atkinson K. Semin Cell Dev Biol; 2007 Dec 01; 18(6):846-58. PubMed ID: 18024097 [Abstract] [Full Text] [Related]
5. From bone to brain: human skeletal stem cell therapy for stroke. Zhou S. Cent Nerv Syst Agents Med Chem; 2011 Jun 01; 11(2):157-63. PubMed ID: 21521166 [Abstract] [Full Text] [Related]
6. Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Zangi L, Margalit R, Reich-Zeliger S, Bachar-Lustig E, Beilhack A, Negrin R, Reisner Y. Stem Cells; 2009 Nov 01; 27(11):2865-74. PubMed ID: 19750539 [Abstract] [Full Text] [Related]
7. An engineered biomarker system to monitor and modulate immune clearance of cell therapies. Singleton A, Khong D, Chin LY, Mukundan S, Li M, Parekkadan B. Cytotherapy; 2017 Dec 01; 19(12):1537-1545. PubMed ID: 28917628 [Abstract] [Full Text] [Related]
8. Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia. Kucic T, Copland IB, Cuerquis J, Coutu DL, Chalifour LE, Gagnon RF, Galipeau J. Am J Physiol Renal Physiol; 2008 Aug 01; 295(2):F488-96. PubMed ID: 18524862 [Abstract] [Full Text] [Related]
9. Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation. Ringdén O. Stem Cells Dev; 2009 Nov 01; 18(9):1243-6. PubMed ID: 19905962 [No Abstract] [Full Text] [Related]
12. Adipose mesenchymal stromal cells minimize and repair radiation-induced oral mucositis. Maria OM, Shalaby M, Syme A, Eliopoulos N, Muanza T. Cytotherapy; 2016 Sep 01; 18(9):1129-45. PubMed ID: 27424150 [Abstract] [Full Text] [Related]
13. Syngeneic, in contrast to allogeneic, mesenchymal stem cells have superior therapeutic potential following spinal cord injury. Hakim R, Covacu R, Zachariadis V, Frostell A, Sankavaram S, Svensson M, Brundin L. J Neuroimmunol; 2019 Mar 15; 328():5-19. PubMed ID: 30551037 [Abstract] [Full Text] [Related]